CKD is one of the quietest yet most devastating diseases of our time. But it also offers a mirror showing us what’s broken in ...

David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...

Chronic kidney disease (CKD) is the progressive and irreversible loss of kidney function. This affects essential bodily functions, including mineral balance, red blood cell production, and waste ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for ...

A modified surgical face mask containing a specialized breath sensor can accurately detect when someone has kidney disease, ...

A decision is expected in the fourth quarter of 2025.

The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 28, 2025, for OLC. Unicycive continues to ...

A new study from Johns Hopkins University has found that a popular cholesterol-lowering drug called rosuvastatin might ...

ProKidney Corp. reported Tuesday a larger first-quarter loss at $16.7 million as the Winston-Salem biopharmaceutical ...

The FDA has freed Amgen’s mysterious early-stage obesity asset from a clinical hold, with the phase 1 study now enrolling ...

CCMC Health System announces the results of a four-years long study on the efficacy of a novel treatment intervention, the ...

Observational studies at the SCAI meeting favored the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) over ...